Breakthrough Extraction Technology Drives Innovation in the Collagen Industry-Moksha

07 Jan Breakthrough Extraction Technology Drives Innovation in the Collagen Industry-Moksha

Recently, L’Oréal’s restructured Type III collagen cream has gained widespread attention from women across global markets, bringing collagen back into the public spotlight. Recombinant collagen refers to collagen produced using genetic engineering techniques, where the gene sequences responsible for the features and functions of human collagen are optimized and redesigned. This collagen is then produced through various host cells, such as transgenic mice, insects, transgenic silkworms, transgenic tobacco, E. coli, and yeast. Collagen produced through this technology offers advantages such as high safety, batch-to-batch stability, pure composition, high activity, and no immune rejection.

In the context of continuous progress in biotechnology, Moksha Group remains at the forefront of collagen extraction and application, thanks to its exceptional R&D capabilities. Our team is dedicated to driving technological innovation, integrating advanced protein extraction processes to provide high-quality collagen ingredients for the global cosmetics industry.

Recently, we collaborated with leading research teams to explore and apply a breakthrough column-free protein purification technology similar to cSAT2.0 developed by South China University of Technology. This technology combines self-assembling peptides and self-cleaving internal peptides, significantly enhancing protein purity and extraction efficiency. Through this technology, we have successfully addressed the issue of tag re-dissolution found in traditional methods, enabling us to provide a more pure and efficient extraction method for large-scale collagen production.

As a technological pioneer in the industry, Moksha Group’s collagen products not only deliver exceptional skin-repairing benefits but are also widely used in cosmetics, pharmaceuticals, and medical fields due to their natural activity. We are committed to continuous innovation, striving to provide the highest quality collagen through research and development, enriching the health and beauty of consumers worldwide.

Looking ahead, Moksha Group will continue to deepen its research in collagen extraction and application, contributing more technological breakthroughs to the industry’s development.

近日，欧莱雅的重组三型胶原蛋白面霜收到各个市场女性的追捧，胶原蛋白再一次走进大众的视线，重组胶原蛋白是指利用基因工程技术生产胶原蛋白，将人胶原蛋白的特征和主要功能域重新优化设计基因序列，然后通过选用各种宿主细胞，如转基因鼠、昆虫、转基因蚕、转基因烟草、大肠杆菌、酵母等生产重组人源胶原蛋白。该技术生产的胶原蛋白具有安全性高、批次稳定、组分单一、活性高、无免疫排异等优点。

在生物技术的持续进步中，望莎集团凭借其卓越的研发实力，在胶原蛋白的提取和应用领域中持续领跑。我们的研发团队不断推动技术创新，结合先进的蛋白提取工艺，为全球化妆品行业提供高质量的胶原蛋白原料。

最近，我们与领先的科研团队共同探讨并应用了类似于华南理工大学的cSAT2.0技术——一种突破性无柱蛋白纯化技术。该技术采用自组装肽与自切割内含肽的巧妙结合，极大地提高了蛋白的纯度和提取效率。通过这一技术，我们成功解决了传统方法中的标签重溶问题，能够为胶原蛋白的规模化生产提供更加纯净和高效的提取方式。

作为行业的技术先锋，望莎集团的胶原蛋白产品不仅具备高效的皮肤修复效果，还因其天然活性而广泛应用于化妆品、药品及医疗领域。我们始终坚持创新，致力于通过研发提供最优质的胶原蛋白，为全球消费者带来更加健康和美丽的生活体验。

未来，我们将继续深化在胶原蛋白提取和应用领域的研究，为行业发展贡献更多技术突破。